Challenges for Decentralized Clinical Trials: Will they be effective? Many life sciences organizations had to quickly adopt remote data collection processes and technologies while conducting clinical trials during the Coronavirus pandemic. This was done to keep clinical trials running and to ensure patients’ safety. Consequently, a lot of organizations adopted decentralized clinical trial models in…
Decentralized clinical trial technologies (DCTs) may include at least one of the following patient engagement components: wearable sensors to collect data from a patient, telemedicine, ePRO (electronic patient-reported outcomes), eConsent, and delivery of study devices, medication, as well as other supplies directly to patients through an RTSM (randomization and trial supply management system). It doesn’t…
Recently, the decentralized clinical trials have become an important topic of development and discussion, which is enabled further by the progression of available technologies. Here are some advantages of decentralizing clinical trials. Decentralized Clinical Trials – Less Disruption of Daily Life While participation offers patients new hope and access to a promising new therapy, it…